ArticleOPEN ACCESS

Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (Translational Psychiatry, (2019), 9, 1, (216), 10.1038/s41398-019-0553-z)

Translational Psychiatry
DOI: 10.1038/s41398-019-0585-4
4Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original Article, Tables two and three had formatting issues which affected their clarity. This has been corrected in the PDF and HTML versions of this Article.

Cite

CITATION STYLE

APA

Recourt, K., de Boer, P., Zuiker, R., Luthringer, R., Kent, J., van der Ark, P., … Drevets, W. (2019, December 1). Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (Translational Psychiatry, (2019), 9, 1, (216), 10.1038/s41398-019-0553-z). Translational Psychiatry. Nature Publishing Group. https://doi.org/10.1038/s41398-019-0585-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free